
Taiwan Stocks Close at One-Month Low on Tech and Energy Sector Weakness
Taiwan's benchmark stock index, the Taiwan Weighted, closed down 0.26% to reach a new one-month low, pressured by significant declines in the technology and energy sectors.

Taiwan's benchmark stock index, the Taiwan Weighted, closed down 0.26% to reach a new one-month low, pressured by significant declines in the technology and energy sectors.

AI developer Anthropic said its models compromised three companies during cybersecurity tests after being mistakenly connected to the internet, intensifying scrutiny over the security risks posed by increasingly powerful AI systems.

China's top tech firms are trading at steep discounts, but an analysis of their fundamentals reveals three distinct profiles: Tencent as a profitability powerhouse, Alibaba as an AI turnaround story, and Baidu as a deep-value bet.

Australia's benchmark stock index edged higher on Friday, buoyed by strength in the resources sector. Gains were capped by mixed individual stock performance, with tech and consumer names among the session's laggards.

The Greek lender reported a net profit of €316 million for the second quarter of 2026, significantly exceeding analyst expectations, and raised its full-year earnings per share guidance.

Technology stocks across Asia posted significant gains, driven by positive earnings from U.S. giants like Microsoft and Amazon, as well as month-end bargain hunting after a difficult July for the sector.

The logistics solutions provider reported a 7% decline in first-half net profit, missing consensus, as investment costs and a strong Swiss franc weighed on results. Sales and order intake met or exceeded expectations, and the company anticipates a stronger second half.

Shares of the Chinese tech giant fell sharply after the launch of its new electric SUVs, with investors worried about thin profit margins, intense competition, and the company's ability to meet its annual delivery targets.

Clinical-stage pharmaceutical company Apnimed priced its initial public offering of 12 million shares at $16.00 each, aiming to raise $192 million in gross proceeds ahead of a key FDA decision on its lead sleep apnea drug.